Deal sheet
- Sector
- Healthcare
- Mandate
- Buy-Side
- Year
- 2018
- Country
- Brazil
H.Hemo acquired Fujisan.
JK Capital acted as exclusive financial advisor to H.Hemo.
Healthcare · Buy-Side · 2018
H.Hemo acquired Fujisan.
H.Hemo acquired Fujisan. JK Capital acted as exclusive financial advisor to H.Hemo. Buy-Side mandate in Healthcare, 2018.
JK Capital acted as exclusive financial advisor to H.Hemo.
More deals in this sector
- Sell-Side · 2026Grupo Fleury (FLRY3) acquired Unilab, a clinical laboratory network in Atibaia and the surrounding region.
- Debt Capital Markets · 2025Issuance of a Commercial Note by Grupo Cartão de Todos, in the amount of R$82.5 million.
- Sell-Side · 2025Grupo Fleury (FLRY3) acquired 100% of Confiance.
Some operations conducted by JK Capital are not disclosed due to buyer and/or seller strategy.